Tag: ENDRA Life Sciences Inc.

NDRA has 36-month beta value of 1.06. Analysts have mixed views on the stock, with 0 analysts rating it as a “buy,” 0 as “overweight,”

The 36-month beta value for NDRA is also noteworthy at 1.01. There are mixed opinions on the stock, with 1 analysts rating it as a

In the past week, NDRA stock has gone down by -20.36%, with a monthly decline of -28.36% and a quarterly plunge of -53.92%. The volatility

Moreover, the 36-month beta value for NDRA is 1.03. Analysts have varying opinions on the stock, with 0 analysts rating it as a “buy,” 0